First-Ever FDA Approval for Cholangiocarcinoma

]]>(MedPage Today) -- WASHINGTON--The fibroblast growth factor receptor (FGFR) inhibitor pemigatinib (Pemazyre) received the first-ever FDA approval for cholangiocarcinoma associated with FGFR-2 gene fusions or certain other rearrangements.The...